COPD Archive

Long-Term Inhaled Corticosteroid Use in COPD May Increase Fracture Risk

Long-Term Inhaled Corticosteroid Use in COPD May Increase Fracture Risk

Patients with chronic obstructive pulmonary disease had a modest increased risk for hip and upper extremity fractures when taking long-term, high-dose inhaled corticosteroids.

COPD-Related Lung Transplantation: How Can We Improve Survival Rates?

COPD-Related Lung Transplantation: How Can We Improve Survival Rates?

Lung transplantation can improve survival in patients with chronic obstructive pulmonary disease, but several variables can affect the surgery's success.

Palliative Care for COPD: Physicians' Views and Treatment Patterns

Palliative Care for COPD: Physicians' Views and Treatment Patterns

Researchers conducted an anonymous survey of medical trainees with a case vignette to determine attitudes regarding palliative care for chronic obstructive pulmonary disease.

Antibiotics for Acute Exacerbations in COPD: Comparison of Effectiveness and Tolerability

Antibiotics for Acute Exacerbations in COPD: Comparison of Effectiveness and Tolerability

Researchers compared the clinical cure and adverse effect rates of multiple antibiotics in the treatment of acute exacerbations in chronic obstructive pulmonary disease.

Blood Biomarkers Add Value to COPD Mortality Predictive Model

Blood Biomarkers Add Value to COPD Mortality Predictive Model

High levels of C-reactive protein and neutrophils as well as low eosinophil count predicted a poor prognosis in COPD.

Respiratory Symptoms in Young Adults: Prognostic Value for Later Lung Function?

Respiratory Symptoms in Young Adults: Prognostic Value for Later Lung Function?

Respiratory symptoms that develop between the ages of 18 and 30 may hold prognostic value for later decline in lung function.

Guiding COPD Management Using Airway Branch Variation

Guiding COPD Management Using Airway Branch Variation

Researchers examined variation in airway branches to determine whether they have an effect on the course of chronic obstructive pulmonary disease.

COPD Exercise Capacity With Long-Acting Bronchodilators

COPD Exercise Capacity With Long-Acting Bronchodilators

Patients with COPD experienced a weighted mean increase in exercise endurance time following treatment with long-acting bronchodilators.

COPD Study Supports Concomitant Beta-Blocker Use in Moderate to Severe Disease

COPD Study Supports Concomitant Beta-Blocker Use in Moderate to Severe Disease

Lung function may not differ between individuals who take beta-blockers vs those who do not for moderate to severe chronic obstructive pulmonary disease.

Clinical Challenge: Elderly Man Presents With Dyspnea at Rest and Chronic Cough

Clinical Challenge: Elderly Man Presents With Dyspnea at Rest and Chronic Cough

An 80-year-old man with a history of smoking, hypertension, diabetes, and COPD presents to the emergency department with dyspnea at rest and chest tightness.

Predicting COPD Exacerbations, Treatment Responses via Eosinophil Counts

Predicting COPD Exacerbations, Treatment Responses via Eosinophil Counts

COPD exacerbation risk and treatment response may be predicted using blood eosinophil counts.

Procalcitonin-Guided Pneumonia Treatment Associated With Improved Outcomes

Procalcitonin-Guided Pneumonia Treatment Associated With Improved Outcomes

Procalcitonin may decrease mortality rates in patients with acute respiratory infections, including pneumonia.

COPD Mortality Predictions by GOLD 2017 vs Previous Versions

COPD Mortality Predictions by GOLD 2017 vs Previous Versions

Although the 2017 GOLD classification did not better predict mortality in patients with chronic obstructive pulmonary disease overall, it did so when patients were extensively categorized by severity.

COPD Continues to Present Screening Challenges, Research Barriers

COPD Continues to Present Screening Challenges, Research Barriers

No data have demonstrated improved mortality, morbidity, or quality of life as a result of screening for COPD in asymptomatic individuals.

Postoperative Pulmonary Complications With Asthma or COPD

Postoperative Pulmonary Complications With Asthma or COPD

Researchers found various risk factors for postoperative pulmonary complications in patients with either asthma or COPD.

Preventing COPD Exacerbations in Upper Respiratory Tract Infections

Preventing COPD Exacerbations in Upper Respiratory Tract Infections

A significant reduction in severe COPD exacerbations was seen with intensified combination therapy at the onset of upper respiratory tract infections.

COPD Home-Based Coaching Intervention: Effects on Physical Activity, Healthcare Utilization

COPD Home-Based Coaching Intervention: Effects on Physical Activity, Healthcare Utilization

Patients with COPD may increase their physical activity levels using a home-based coaching intervention.

Stable Hypercapnic COPD May Benefit From At-Home High-Flow Nasal Cannula Oxygen Therapy

Stable Hypercapnic COPD May Benefit From At-Home High-Flow Nasal Cannula Oxygen Therapy

Patients with stable hypercapnic COPD reported improved health-related quality of life after 6 weeks of at-home high-flow nasal cannula oxygen therapy.

Inhaled Long-Acting Bronchodilators for COPD: Potential Cardiovascular Risk

Inhaled Long-Acting Bronchodilators for COPD: Potential Cardiovascular Risk

Within the first 30 days of therapy, patients with COPD who began using long-acting bronchodilators had a 1.5-fold increased risk for cardiovascular events.

COPD and Asthma Risk in Women With Rheumatoid Arthritis

COPD and Asthma Risk in Women With Rheumatoid Arthritis

Women with rheumatoid arthritis had an increased risk for chronic obstructive pulmonary disease, but did not have an increased risk for asthma compared with women without RA.

Effect of Beta-Blockers on Hospitalization in COPD and Concurrent Heart Failure

Effect of Beta-Blockers on Hospitalization in COPD and Concurrent Heart Failure

Carvedilol may increase the risk for hospitalization in patients with concurrent heart failure and COPD compared with metoprolol/bisoprolol/nebivolol.

A Middle-Aged Man With Worsening COPD

A Middle-Aged Man With Worsening COPD

A middle-aged man diagnosed with COPD presents with shortness of breath at rest with no improvement with nebulizer treatments.

Progression of Emphysema With Regular Aspirin Use

Progression of Emphysema With Regular Aspirin Use

Regular use of aspirin may slow the progression of emphysema.

Nasal High-Flow Oxygen Corrects Hypoxemia, Reduces Hypercapnia in COPD

Nasal High-Flow Oxygen Corrects Hypoxemia, Reduces Hypercapnia in COPD

Nasal high-flow oxygen therapy may be a safe and effective therapy for patients with normocapnic and hypercapnic COPD.

Chronic Lung Disease Research in the Pipeline: An Interview With Augustine M.K. Choi, MD

Chronic Lung Disease Research in the Pipeline: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Examining the Efficacy of Carbon Monoxide Therapy in Idiopathic Pulmonary Fibrosis: An Interview With Augustine M.K. Choi, MD

Examining the Efficacy of Carbon Monoxide Therapy in Idiopathic Pulmonary Fibrosis: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Identifying New Therapeutics for Pulmonary Diseases: An Interview With Augustine M.K. Choi, MD

Identifying New Therapeutics for Pulmonary Diseases: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD of Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Overview of Autophagy Research in COPD: An Interview With Augustine M.K. Choi, MD

Overview of Autophagy Research in COPD: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

FDA Approves First Nebulized Long-Acting Muscarinic Antagonist for COPD

FDA Approves First Nebulized Long-Acting Muscarinic Antagonist for COPD

Adults treated with Lonhala Magnair showed statistically significant and clinically important changes in FEV1 at week 12 vs placebo.

Walking in Polluted Area Blunts Cardiorespiratory Benefits

Walking in Polluted Area Blunts Cardiorespiratory Benefits

Concentrations of black carbon, nitrogen dioxide, and particulate matter were higher in traffic-polluted areas, and linked to more instances of cough, sputum, and shortness of breath.

Predicting COPD Exacerbations Using Sputum vs Blood Eosinophils

Predicting COPD Exacerbations Using Sputum vs Blood Eosinophils

Sputum eosinophil counts may be a better predictor of COPD exacerbations compared with serum blood eosinophil counts.

COPD Adverse Outcomes May Increase With Loop Diuretic Use

COPD Adverse Outcomes May Increase With Loop Diuretic Use

Older patients with COPD who use loop diuretics may be at an increased risk for respiratory-related morbidity and mortality.

Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Related to COPD

Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Related to COPD

Noninvasive ventilation may reduce mortality in patients with acute hypercapnic respiratory failure related to COPD.

COPD Hospitalization Outcomes Affected by Obesity

COPD Hospitalization Outcomes Affected by Obesity

Patients with obesity who are hospitalized for an acute exacerbation of COPD may have longer hospital stays and more often require mechanical ventilation.

Long-Term Inhaled Corticosteroid Use Associated With Increased Sputum Bacterial Load in COPD

Long-Term Inhaled Corticosteroid Use Associated With Increased Sputum Bacterial Load in COPD

Salmeterol plus fluticasone was associated with a significant increase in sputum bacterial load in chronic obstructive pulmonary disease, compared to salmeterol alone.

COPD Hospitalization Risk With Rheumatoid Arthritis

COPD Hospitalization Risk With Rheumatoid Arthritis

Rheumatoid arthritis increased the risk of COPD-related hospitalization by 47%.

Impulse Oscillometry vs Spirometry for Measuring COPD Airway Obstruction

Impulse Oscillometry vs Spirometry for Measuring COPD Airway Obstruction

Impulse oscillometry is a better monitor of airway obstruction compared with spirometry in patients with chronic obstructive pulmonary disease.

Beta Blockers Linked to Longer Life Expectancy in COPD

Beta Blockers Linked to Longer Life Expectancy in COPD

In a retrospective analysis, researchers examined the efficacy of beta blocker therapy in prolonging patients' lives.

COPD Hospital Readmission, Mortality Risk Predicted by 3-Variable Score

COPD Hospital Readmission, Mortality Risk Predicted by 3-Variable Score

A 3-variable score that encompasses dyspnea score, prednisone use, and prior hospitalization for COPD exacerbations can predict mortality and readmission risk.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.

Restrictive Spirometry Pattern Associated With Increased Arterial Stiffness

Restrictive Spirometry Pattern Associated With Increased Arterial Stiffness

Both reduced forced vital capacity and a restrictive spirometry pattern was associated with arterial stiffness in both men and women.

Chronic Respiratory Disease Mortality Rates Increase From 1980 to 2014

Chronic Respiratory Disease Mortality Rates Increase From 1980 to 2014

Mortality rates and changes in mortality rates for chronic respiratory diseases in the United States varied by county, sex, and particular disease type.

Inhaled Corticosteroids Do Not Increase Risk for Pneumonia in COPD

Inhaled Corticosteroids Do Not Increase Risk for Pneumonia in COPD

In contrast to previous study findings, inhaled corticosteroids do not appear to increase risk for pneumonia in patients with COPD with moderate airflow limitation.

Using Coronary Artery Calcium to Predict Cardiovascular Events in COPD

Using Coronary Artery Calcium to Predict Cardiovascular Events in COPD

Coronary artery calcium may be the best noninvasive risk marker for predicting cardiovascular events in patients with chronic obstructive pulmonary disease.

LABA Plus LAMA Therapy Associated With Fewer Exacerbations in COPD

LABA Plus LAMA Therapy Associated With Fewer Exacerbations in COPD

Long-acting muscarinic antagonists plus long-acting beta-agonists for COPD is associated with fewer exacerbations compared with long-acting beta-agonists plus inhaled corticosteroids.

Targeting Blood Eosinophil Counts in COPD Treatment

Targeting Blood Eosinophil Counts in COPD Treatment

Patients with COPD who have elevated blood eosinophilic levels may benefit from treatment with mepolizumab.

Airway Mucin May Serve as Confirmatory Biomarker for Chronic Bronchitis

Airway Mucin May Serve as Confirmatory Biomarker for Chronic Bronchitis

Current and former smokers with COPD had much higher total airway mucin concentrations compared with patients who had never smoked.

Palliative Care Approaches for Patients with Chronic Obstructive Pulmonary Disease

Palliative Care Approaches for Patients with Chronic Obstructive Pulmonary Disease

A multidisciplinary palliative care team may significantly benefit patients with chronic obstructive pulmonary disease.

Treating Early-Stage Chronic Obstructive Pulmonary Disease With Tiotropium

Treating Early-Stage Chronic Obstructive Pulmonary Disease With Tiotropium

In patients with mild or moderate chronic obstructive pulmonary disease, tiotropium improved the decline in FEV1, as well as quality of life.

Potential Role for Statins in COPD Treatment Armamentarium

Potential Role for Statins in COPD Treatment Armamentarium

Patients with COPD and comorbid cardiovascular disease may benefit from statin treatment depending on their C - reactive protein levels.

Is Undiagnosed COPD Common in Patients Living at High Altitudes?

Is Undiagnosed COPD Common in Patients Living at High Altitudes?

After accounting for individual risk factors, living altitude is not associated with variability in COPD prevalence.

Treating Eosinophilic COPD With Mepolizumab

Treating Eosinophilic COPD With Mepolizumab

Two phase 3 clinical trials examined mepolizumab 100 or 300 mg vs placebo to treat moderate-to-severe COPD exacerbations.

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

Researchers hypothosized that increased sputum Gammaproteobacteria:Firmicutes ratio may serve as a biomarker to guide antibiotic treatment in COPD.

Reduced Mortality Risk in COPD Linked to Statin Tx

Reduced Mortality Risk in COPD Linked to Statin Tx

People with COPD have been found to benefit from statin therapies, with reduced risk of all-cause and pulmonary-related mortality.

COPD Exacerbations May Be Reduced With Mucolytic Agents

COPD Exacerbations May Be Reduced With Mucolytic Agents

Patients with COPD treated with mucolytic agents for at least 1 year were better protected against exacerbations compared with patients treated with placebo.

COPD Diagnosis by Physician vs Spirometry: A Validation Study

COPD Diagnosis by Physician vs Spirometry: A Validation Study

Questions involving physician-diagnosed COPD have a low sensitivity and a high specificity.

Efficacy of Tiotropium in Mild to Moderate COPD Examined

Efficacy of Tiotropium in Mild to Moderate COPD Examined

FEV1 was higher in patients who received tiotropium therapy vs those in the placebo group.

COPD Linked to Diabetes and Post-Diabetes Pneumonia

COPD Linked to Diabetes and Post-Diabetes Pneumonia

Patients with chronic obstructive pulmonary disease, particularly with exacerbations, have an increased risk for diabetes development.

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

A 2015 update from the 1990 Global Burden of Disease study reveals current prevalence and mortality of asthma and chronic obstructive pulmonary disease.

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Study results showed the benefit of single-inhaler triple therapy vs ICS/LABA therapy in COPD.

Does Procalcitonin Testing in COPD Impact Antibiotic Rx?

Does Procalcitonin Testing in COPD Impact Antibiotic Rx?

Researchers found a weak negative association between PCT testing rate and risk-adjusted antibiotic initiation rate.

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Inhaled corticosteroids for COPD does not increase the risk for fractures when used for short-term periods.

Respiratory Therapist Autonomy With Noninvasive Ventilation May Improve COPD Outcomes

Respiratory Therapist Autonomy With Noninvasive Ventilation May Improve COPD Outcomes

Timely selection and early intervention, attention to comfort, and frequent checks improved outcomes in patients with chronic obstructive pulmonary disease who were treated with noninvasive ventilation.

Errors in Spirometry, Primary Care Contribute to COPD Misdiagnosis

Errors in Spirometry, Primary Care Contribute to COPD Misdiagnosis

Chronic obstructive pulmonary disease may be misdiagnosed in patients as a result of errors related to spirometry tests, errors made in primary care, and differential diagnoses, among others.

Loss of Lung Function Slowed With Fluticasone Furoate Tx

Loss of Lung Function Slowed With Fluticasone Furoate Tx

The rate of forced expiratory volume in one second decline in patients with moderate COPD can be reduced by regular use of fluticasone furoate, either alone or in combination with vilanterol.

Avoiding Pneumonia in Patients With COPD

Avoiding Pneumonia in Patients With COPD

Pneumonia primarily affects young children, smokers, adults 65 years and older, and people with COPD.

Boosting Rehabilitation in Adults With COPD Through Social Support

Boosting Rehabilitation in Adults With COPD Through Social Support

Researchers examined structural social support indicators, including living status, having a partner, number of close friends and relatives, and the presence of a family caregiver.

LABA/LAMA Combination Therapy Associated With Lower CV, Cerebrovascular Risks in COPD

LABA/LAMA Combination Therapy Associated With Lower CV, Cerebrovascular Risks in COPD

Cardio- and cerebrovascular events were more common in patients being treated with combination long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) therapies vs LABA/inhaled corticosteroids.

Diagnostic Measures of Lung Function Decline in COPD

Diagnostic Measures of Lung Function Decline in COPD

Comparative measures of inspiratory vs expiratory volumes show a penumbra of lung tissue at higher risk of damage from existing COPD.

Managing COPD Exacerbations With Doxycycline Plus Prednisone

Managing COPD Exacerbations With Doxycycline Plus Prednisone

The first study of antibiotic use in outpatients with COPD exacerbations found that doxycycline plus prednisone did not prolong the time between exacerbations.

Greater Benefit With Azithromycin in COPD Patients With H pylori

Greater Benefit With Azithromycin in COPD Patients With H pylori

Azithromycin therapy is more effective at preventing COPD exacerbations among patients with Helicobacter pylori infection than among those who are H pylori seronegative.

Once-Daily Triple Therapy Effective in Patients With COPD

Once-Daily Triple Therapy Effective in Patients With COPD

In a real-world study, once-daily, single-inhaler triple therapy reduced COPD exacerbations more than twice-daily double therapy.

Fluticasone Propionate-Induced Myopathy in HIV with COPD

Fluticasone Propionate-Induced Myopathy in HIV with COPD

The patient presented with obesity and reduction in bilateral hip flexion strength and shoulder abduction.

Using Chest CT in Evaluation, Management of COPD

Using Chest CT in Evaluation, Management of COPD

Chest CT is not currently part of recommended routine COPD care.

How Does CVD Comorbidity Influence Bronchodilator Tx in COPD?

How Does CVD Comorbidity Influence Bronchodilator Tx in COPD?

Associated cardiovascular side effects of bronchodilators may reduce prescription rates in patients with COPD with comorbid cardiovascular disease.

New Opioid Use in Older Adults With COPD May Up Cardiac Events

New Opioid Use in Older Adults With COPD May Up Cardiac Events

Odds of ischemic heart disease-related morbidity, mortality increased after new opioid use

Efficacy of Home Noninvasive Ventilation With Oxygen Therapy in COPD, Hypercapnia

Efficacy of Home Noninvasive Ventilation With Oxygen Therapy in COPD, Hypercapnia

Patients with persistent hypercapnia following acute exacerbation of COPD, home noninvasive ventilation with home oxygen therapy prolonged readmission time.

Maintenance Therapy With Tiotropium Bronchodilator in Uncontrolled Asthma

Maintenance Therapy With Tiotropium Bronchodilator in Uncontrolled Asthma

Two phase 3 clinical development programs showed improved breathing in children and adolescents with moderate-to-severe asthma regardless of allergic status.

Improving Lung Function in COPD With Indacaterol/Glycoptrrolate Inhaler

Improving Lung Function in COPD With Indacaterol/Glycoptrrolate Inhaler

Multiple studies presented at ATS 2017 indicated that indacaterol/glycoptrrolate inhaler therapy results in clinically significant improvements in COPD-related quality of life.

Do Bundled Payments Cut COPD Readmissions?

Do Bundled Payments Cut COPD Readmissions?

No difference was noted in all-cause readmission rates in the intervention vs non-intervention groups.

NIH: National Action Plan Unifies Approach to Ending US COPD Crisis

NIH: National Action Plan Unifies Approach to Ending US COPD Crisis

The release of a new autonomous approach for terminating the COPD crisis has been lead by the National Heart, Lung and Blood Institute (NHLBI).

Reducing Exacerbations in Moderate-to-Severe COPD With Beta-Blocker Therapy

Reducing Exacerbations in Moderate-to-Severe COPD With Beta-Blocker Therapy

Researchers examined the relationship between COPD and right and left ventricular morphometry to determine which patients may better respond to beta-blocker therapies.

Efficacy of Online Pulmonary Rehabilitation for COPD Evaluated

Efficacy of Online Pulmonary Rehabilitation for COPD Evaluated

Online pulmonary rehabilitation is non-inferior to face-to-face rehabilitation for patients with COPD, according to research presented at ATS 2017.

Home Oxygen Services Subpar for Patients With Lung Disease

Home Oxygen Services Subpar for Patients With Lung Disease

A new survey shows that home oxygen services create barriers for patients with lung disease.

Triple Therapy Superior to Long-acting Muscarinic Antagonist for COPD

Triple Therapy Superior to Long-acting Muscarinic Antagonist for COPD

The TRINITY study reports the significant benefits to extafine triple therapy taken in a single inhaler compared with tiotropium in chronic obstructive pulmonary disease.

Roflumilast Reduces Rate of COPD Exacerbations

Roflumilast Reduces Rate of COPD Exacerbations

Simulated studies were key to the approval of roflumilast for reducing COPD exacerbations.

Clinical Characteristics of Eosinophilic COPD vs COPD With Asthma

Clinical Characteristics of Eosinophilic COPD vs COPD With Asthma

Patients with COPD and asthma can be characterized by the presence of allergies and more exacerbation with less eosinophilic inflammation.

Residual Volume, Pulmonary Hyperinflation Increase Pulmonary Artery Size in COPD

Residual Volume, Pulmonary Hyperinflation Increase Pulmonary Artery Size in COPD

Study results suggest that gas trapping, not emphysema, is associated with pulmonary vascular remodeling in COPD.

Long-Acting Beta2-Agonists Do Not Increase Cardiovascular Risks

Long-Acting Beta2-Agonists Do Not Increase Cardiovascular Risks

Combination therapy with an inhaled LABA and inhaled corticosteroid did not affect all-cause mortality in patients with COPD compared with inhaled placebo, LABA alone, or corticosterioid alone.

Respiratory Effects of Cannabis: a National Academies Report

Respiratory Effects of Cannabis: a National Academies Report

The National Academies of Sciences, Engineering, and Medicine released a report titled "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendation for Research."

COPD Management of Elderly Patients by Empowerment

COPD Management of Elderly Patients by Empowerment

Demographic, family and social factors are important in the role of empowering elderly patients with chronic obstructive pulmonary disease.

Utibron Neohaler Available for Maintenance Treatment of COPD

Utibron Neohaler Available for Maintenance Treatment of COPD

Sunovion announces Utibron Neohaler, an inhalation powder for the long term maintenance treatment of airflow obstruction in COPD patients.

Page 2 of 3

Sign Up for Free e-newsletters